Do Omega-6 and Trans Fatty Acids Play a Role in Complex Regional Pain Syndrome? A Pilot Study

Pain Medicine

Volumn 11, Issue 7, 2010, Pages 1115-1125

  Ramsden, Christopher ^a   Gagnon, Christine ^a   Graciosa, Joseph ^a   Faurot, Keturah ^b   David, Robert ^c   Bralley, J Alexander ^c   Harden, R Norman ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Metametrix Clinical Laboratory   (United States)

Author keywords

Arachidonic Acid; Chronic Pain; CRPS; Omega 3; Omega 6; Trans Fatty Acids

Indexed keywords

ADRENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRANS FATTY ACID;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DIET RESTRICTION; DISABILITY SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PAIN MEASUREMENT; PATHOPHYSIOLOGY;

ADULT; CASE-CONTROL STUDIES; COMPLEX REGIONAL PAIN SYNDROMES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; TRANS FATTY ACIDS;

EID: 77955123727     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00882.x     Document Type: Article

References (76)

1. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007, 8(4):326-31.
2. Alexander GM, Perreault MJ, Reichenberger ER, Schwartzman RJ. Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome. Brain Behav Immun 2007, 21(5):668-76.
3. Uceyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain 2007, 132(1-2):195-205.
4. Schinkel C, Kirschner MH. Status of immune mediators in complex regional pain syndrome type I. Curr Pain Headache Rep 2008, 12(3):182-5.
5. Geha PY, Baliki MN, Harden RN. The brain in chronic CRPS pain: Abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008, 60(4):570-81.
6. Del Valle L, Schwartzman RJ, Alexander G. Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. Brain Behav Immun 2009, 23(1):85-91.
7. Harden RN, Swan M, King A, Costa B, Barthel J. Treatment of complex regional pain syndrome: Functional restoration. Clin J Pain 2006, 22(5):420-4.
8. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129(1-2):210-23.
9. Freeman MP, Hibbeln JR, Wisner KL. Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006, 67(12):1954-67.
10. Hibbeln JR, Davis JM. Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2009, 81(2-3):179-86.
11. Sastry PS. Lipids of nervous tissue: Composition and metabolism. Prog Lipid Res 1985, 24(2):69-176.
12. Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 2008, 79(3-5):101-8.
13. Meves H. Arachidonic acid and ion channels: An update. Br J Pharmacol 2008, 155(1):4-16.
14. Young C, Gean PW, Chiou LC, Shen YZ. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 2000, 37(2):90-4.
15. Hibbeln JR, Linnoila M, Umhau JC. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 1998, 44(4):235-42.
16. Lands WE, Libelt B, Morris A. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992, 1180(2):147-62.
17. Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand 2001, 59(6):348-55.
18. Martin HA, Basbaum AI, Goetzl EJ, Levine JD. Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat. J Neurophysiol 1988, 60(2):438-45.
19. Wada M, DeLong CJ, Hong YH. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007, 282(31):22254-66.
20. Serhan CN. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids 2008, 79(3-5):157-63.
21. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996, 174(4):1335-8.
22. Eriksen W, Sandvik L, Bruusgaard D. Does dietary supplementation of cod liver oil mitigate musculoskeletal pain? Eur J Clin Nutr 1996, 50(10):689-93.
23. Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: An alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 2006, 65(4):326-31.
24. Serhan CN. Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 2005, 105(1):7-21.
25. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr 1999, 19:63-90.
26. Beare-Rogers JL, Gray LM, Hollywood R. The linoleic acid and trans fatty acids of margarines. Am J Clin Nutr 1979, 32(9):1805-9.
27. Ackman RG, Hooper SN. Linolenic acid artifacts from the deodorization of oil. J Am Oil Chemist Soc 1974, 51:42-9.
28. Chardigny JM, Sebedio JL, Grandgirard A. Identification of novel trans isomers of 20:5n-3 in liver lipids of rats fed a heated oil. Lipids 1996, 31(2):165-8.
29. Acar N, Chardigny JM, Darbois M, Pasquis B, Sebedio JL. Modification of the dopaminergic neurotransmitters in striatum, frontal cortex and hippocampus of rats fed for 21 months with trans isomers of alpha-linolenic acid. Neurosci Res 2003, 45(4):375-82.
30. Acar N, Chardigny JM, Berdeaux O, Almanza S, Sebedio JL. Modification of the monoaminergic neurotransmitters in frontal cortex and hippocampus by dietary trans alpha-linolenic acid in piglets. Neurosci Lett 2002, 331(3):198-202.
31. Lopez-Garcia E, Schulze MB, Meigs JB. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005, 135(3):562-6.
32. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: Immune cells and molecules. Anesth Analg 2007, 105(3):838-47.
33. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28(20):5189-94.
34. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008, 9(1):46-56.
35. Koo JW, Duman RS. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 2009, 456(1):39-43.
36. Edwards RR, Kronfli T, Haythornthwaite JA. Association of catastrophizing with interleukin-6 responses to acute pain. Pain 2008, 140(1):135-44.
37. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987, 30(2):191-7.
38. Pollard CA. Preliminary validity study of the Pain Disability Index. Percept Mot Skills 1984, 59(3):974.
39. McCracken LM, Dhingra L. A short version of the Pain Anxiety Symptoms Scale (PASS-20): Preliminary development and validity. Pain Res Manag 2002, 7(1):45-50.
40. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994, 10(2):77-84.
41. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual 1994, Boston, The Health Institute
42. Lepage G, Levy E, Ronco N. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res 1989, 30(10):1483-90.
43. Funk CD. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 2001, 294(5548):1871-5.
44. Smith VA, Beyer CE, Brandt MR. Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli. Brain Res 2006, 1095(1):65-72.
45. Vasquez E, Bar KJ, Ebersberger A. Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. J Neurosci 2001, 21(22):9001-8.
46. Yang H, Chen C. Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des 2008, 14(14):1443-51.
47. Coderre TJ, Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur J Neurosci 1994, 6(8):1328-34.
48. Bianchi M, Martucci C, Ferrario P, Franchi S, Sacerdote P. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: The effects of analgesic drugs. Anesth Analg 2007, 104(4):949-54.
49. Meves H. Modulation of ion channels by arachidonic acid. Prog Neurobiol 1994, 43(2):175-86.
50. Miller B, Sarantis M, Traynelis SF, Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992, 355(6362):722-5.
51. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991, 44(3):293-9.
52. Chang YC, Kim HW, Rapoport SI, Rao JS. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: Cross-talk between excitotoxicity and neuroinflammation. Neurochem Res 2008, 33(11):2318-23.
53. Hibbeln JR, Umhau JC, George DT. Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: Implications for the biophysical role of highly unsaturated fatty acids. Am J Clin Nutr 2000, 71(2):331S-8S. suppl
54. Chalon S, Vancassel S, Zimmer L, Guilloteau D, Durand G. Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission. Lipids 2001, 36(9):937-44.
55. Chapkin RS, McMurray DN, Davidson LA. Bioactive dietary long-chain fatty acids: Emerging mechanisms of action. Br J Nutr 2008, 100(6):1152-7.
56. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996, 31:S157-61. Suppl
57. Dinan T, Siggins L, Scully P. Investigating the inflammatory phenotype of major depression: Focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res 2009, 43(4):471-6.
58. Conklin SM, Manuck SB, Yao JK. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med 2007, 69(9):932-4.
59. Sublette ME, Russ MJ, Smith GS. Evidence for a role of the arachidonic acid cascade in affective disorders: A review. Bipolar Disord 2004, 6(2):95-105.
60. Philbrick DJ, Mahadevappa VG, Ackman RG, Holub BJ. Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina. J Nutr 1987, 117(10):1663-70.
61. Harkewicz R, Fahy E, Andreyev A, Dennis EA. Arachidonate-derived dihomoprostaglandin production observed in endotoxin-stimulated macrophage-like cells. J Biol Chem 2007, 282(5):2899-910.
62. Rosenthal MD, Garcia MC, Jones MR, Sprecher H. Retroconversion and delta 4 desaturation of docosatetraenoate (22:4(n-6)) and docosapentaenoate (22:5(n-3)) by human cells in culture. Biochim Biophys Acta 1991, 1083(1):29-36.
63. Innis SM, Friesen RW. Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 2008, 87(3):548-57.
64. Greiner RS, Catalan JN, Moriguchi T, Salem N. Docosapentaenoic acid does not completely replace DHA in n-3 FA-deficient rats during early development. Lipids 2003, 38(4):431-5.
65. Ozyurt B, Sarsilmaz M, Akpolat N. The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat. Neurochem Int 2007, 50(1):196-202.
66. Ramsden CE, Faurot KR, Carrera-Bastos P. Dietary fat quality and coronary heart disease prevention: A unified theory based on evolutionary, historical, global, and modern perspectives. Curr Treat Options Cardiovasc Med 2009, 11(4):289-301.
67. Stark KD, Mulvad G, Pedersen HS. Fatty acid compositions of serum phospholipids of postmenopausal women: A comparison between Greenland Inuit and Canadians before and after supplementation with fish oil. Nutrition 2002, 18(7-8):627-30.
68. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE. Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am J Clin Nutr 2006, 83:1483S-93S. 6 Suppl
69. Iso H, Sato S, Folsom AR. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol 1989, 18(2):374-81.
70. Watkins LR, Maier SF, Goehler LE. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995, 63(3):289-302.
71. Samad TA, Moore KA, Sapirstein A. Interleukin-1beta-mediated induction of cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410(6827):471-5.
72. Poole H, White S, Blake C, Murphy P, Bramwell R. Depression in chronic pain patients: Prevalence and measurement. Pain Pract 2009, 9(3):173-80.
73. Dickenson AH, Ghandehari J. Anti-convulsants and anti-depressants. Handb Exp Pharmacol 2007, 177:145-77.
74. Cassagno N, Palos-Pinto A, Costet P. Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defence to oxidative stress in mice. Br J Nutr 2005, 94(3):346-52.
75. Loevinger BL, Muller D, Alonso C, Coe CL. Metabolic syndrome in women with chronic pain. Metabolism 2007, 56(1):87-93.
76. Lands WE. Biosynthesis of prostaglandins. Annu Rev Nutr 1991, 11:41-60.